---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-237834"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:50:48.840923+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Corcept terminates distribution agreement with Optime Care, effective Jan 8, 2026

## Summary
- Notice of termination of Distribution Services Agreement with Optime Care given Oct 10, 2025; effective Jan 8, 2026.
- Optime had been specialty pharmacy distributor for Korlym and authorized generic mifepristone.
- Exclusive provider status ended Sept 15, 2025; termination is for convenience under 90-day notice provision.
- Original agreement dated Aug 4, 2017, amended and restated Apr 1, 2024, with term through Mar 31, 2027.

## SEC filing metadata
- accession: 0001193125-25-237834
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000119312525237834/0001193125-25-237834-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000119312525237834/d61706d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-237834
- JSON: https://secwatch.observer/filing/0001193125-25-237834.json
- Plain text: https://secwatch.observer/filing/0001193125-25-237834.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.